Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07VGT
|
||||
Former ID |
DNC011113
|
||||
Drug Name |
6-[4-(Pyridin-4-ylmethyl)phenyl]naphthalen-2-ol
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [531085] | ||
Structure |
Download2D MOL |
||||
Formula |
C22H17NO
|
||||
Canonical SMILES |
C1=CC(=CC=C1CC2=CC=NC=C2)C3=CC4=C(C=C3)C=C(C=C4)O
|
||||
InChI |
1S/C22H17NO/c24-22-8-7-20-14-19(5-6-21(20)15-22)18-3-1-16(2-4-18)13-17-9-11-23-12-10-17/h1-12,14-15,24H,13H2
|
||||
InChIKey |
OCQPVXWUPNNJIV-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 17 alpha-hydroxylase-C17, 20-lyase | Target Info | Inhibitor | [531085] | |
Cytochrome P450 11B1, mitochondrial | Target Info | Inhibitor | [531085] | ||
PathWhiz Pathway | Androgen and Estrogen Metabolism | ||||
SteroidogenesisPW000141:Steroidogenesis | |||||
WikiPathways | Metapathway biotransformation | ||||
Steroid Biosynthesis | |||||
Oxidation by Cytochrome P450 | |||||
Metabolism of steroid hormones and vitamin D | |||||
Glucocorticoid & Mineralcorticoid Metabolism | |||||
Prostate Cancer | |||||
Phase 1 - Functionalization of compoundsWP702:Metapathway biotransformation | |||||
Corticotropin-releasing hormone | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.